Scinovex
reviewTop 1% cited

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

JAMA · 1995 · Vol. 274(13) · pp. 1049–1049
Carol J. Boushey

Abstract

A 5-mumol/L tHcy increment elevates CAD risk by as much as cholesterol increases of 0.5 mmol/L (20 mg/dL). Higher folic acid intake by reducing tHcy levels promises to prevent arteriosclerotic vascular disease. Clinical trials are urgently needed. Concerns about masking cobalamin deficiency by folic acid could be lessened by adding 1 mg of cobalamin to folic acid supplements.

Folate and B Vitamins ResearchEsophageal and GI PathologyPregnancy and preeclampsia studiesMedicineOdds ratioHomocysteineInternal medicineVascular diseaseRisk factorCoronary artery diseasePopulationCardiologyGastroenterology

MeSH terms

ArteriosclerosisCoronary DiseaseFemaleFolic AcidFood, FortifiedHomocysteineHumansMalePyridoxineRisk FactorsVitamin B 12Vitamin B 12 Deficiency
Citations
3,600
FWCI
121.46
field-weighted impact
References
96
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.